← Back to Search

Education + Navigation Support for Lung Cancer Screening

N/A
Waitlist Available
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Self-identify as African American or Black males
Do not self-report a history of lung cancer symptoms
Must not have
Do not speak English
Self-report a history of lung cancer symptoms
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

This trial tests an education and patient navigation intervention to help people quit smoking and access lung cancer screenings.

Who is the study for?
This trial is for African American men who currently smoke and speak English. They must not have symptoms of lung cancer. Former smokers or those with a history of lung cancer symptoms, as well as non-English speakers, cannot participate.Check my eligibility
What is being tested?
The study tests a support program to help participants quit smoking and get screened for lung cancer using educational videos, decision-making tools, and personal navigation support over two months.See study design
What are the potential side effects?
Since this trial involves educational materials and support rather than medical treatments, there are no direct side effects like you'd expect from drugs or surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an African American or Black male.
Select...
I have not experienced symptoms of lung cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.
Select...
I have experienced symptoms of lung cancer.
Select...
I used to smoke but have quit.
Select...
I do not identify as an African American male.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assess changes in knowledge, attitudes, risk perception, and intention/ stage of readiness to engage in lung cancer screening and smoking cessation
Assess completion of referral to smoking cessation treatment
Assess the completion of a healthcare visit for the purpose of lung cancer screening ces

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment4 Interventions
A culturally tailored video that provides education about the process of low-dose helical computed tomography (LDCT) lung cancer screening A culturally tailored shared decision-making tool that educates participants about the shared decision-making process The use of a flip chart that reinforces the information provided in the video and shared decision-making tool Navigation support for participants who express interest in LDCT and quitting smoking

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
618 Previous Clinical Trials
1,564,001 Total Patients Enrolled
~18 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top